Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

This is a single center study to assess the efficacy of CyPath® Early Detection Lung Cancer Assay to detect lung cancer cells from deep lung sputum.

Key facts

Study ID

NCT02388074

Run by

bioAffinity Technologies Inc.

People needed

25

Starts

2015-03-01

Expected to finish

2015-04-01

Last updated by the study team

2015-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participants who have never smoked nor have known lung diseases

You may not qualify if…

• Severe obstructive lung disease
• Angina with minimal exertion
• Pregnancy
• Have or have had cancer other than lung cancer
• Worked in the mining Industry

Where it is running

• Radiology Associates of Albuquerque (RAA) — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.